Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Rating) was the target of a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 62,900 shares, an increase of 88.9% from the November 30th total of 33,300 shares. Based on an average trading volume of 29,800 shares, the days-to-cover ratio is presently 2.1 days.

Mayne Pharma Group Price Performance

Shares of OTCMKTS:MAYNF remained flat at $0.13 during trading on Friday. The firm has a 50-day moving average price of $0.17 and a 200 day moving average price of $0.19. Mayne Pharma Group has a 12 month low of $0.12 and a 12 month high of $0.29.

Shares of Mayne Pharma Group are set to reverse split on Wednesday, January 18th. The 1-20 reverse split was announced on Wednesday, January 18th. The number of shares owned by shareholders will be adjusted after the market closes on Wednesday, January 18th.

Mayne Pharma Group Company Profile

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products.

Read More

• Get a free copy of the StockNews.com research report on Mayne Pharma Group (MAYNF)
• MarketBeat: Week in Review 12/26 – 12/30
• The Dogs Of Tech: It's Time For A Bite Of These Stocks
• Does This Acquisition Make Microsoft a Bear Market Buy?
• Is Kintara Therapeutics A Hidden Gem?
• Should You Warm up to Generac Stock for the Winter?

Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.